VANCOUVER, BC and MESA, AZ, Oct. 17, 2013 /CNW/ - Avidus Management Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary Asantae is pleased to announce that IS2™, a proprietary new functional beverage is now shipping from all company warehouse locations.
Company President, Doug Ridley said, "Ninety days ago we promised a new Asantae and this week we delivered on those promises with the launch of this powerful functional beverage, a dynamic new website (www.asantae.com), two new product videos, and a new business presentation video. It's an exciting time at Asantae as we roll out all these improvements and enhancements. We look forward to an even greater future ahead as the benefits accrue to the company."
According to MarketResearch.com, the functional beverage market had total revenues that exceeded $25 bn in 2012 and annual compounded growth rates of 6% per year for the trailing 5-years. The market is projected to grow to over $38 bn by 2017.
Asantae's formulation team created IS2™ to support the body's natural immune system and inflammatory response. These natural systems function best when they quickly and completely "Recognize, Respond, and Resolve" threats, invasions, infections and injuries in the body. IS2™ is specifically formulated to help these systems function optimally. Among many other ingredients to be discussed in more detailed news, IS2™ features Wellmune™, a powerful new compound with significant research behind it (www.wellmune.com).
"Not only does IS2™ have tremendous health benefits, but it also will dramatically improve our overall gross margins," said Dan Lundell, CEO. He further pointed out, "With comparable margins, IS2™ is an ideal companion to our groundbreaking weight-loss product RealW8™. It has 300% better margins than two of our legacy products. Beyond the obvious benefits of higher gross margins, enabling improved commissions drives recruiting growth and momentum."
Leading distributor Erik Cloud said, "As a full-time network marketing professional who has built my entire career around functional beverages, this is the most functional health beverage I've ever seen. I can build a massive organization in a relatively short time with a product that tastes this good, has benefits that people feel, and is easy for distributors like me to share. The availability of this product at Asantae unleashes a new and powerful phase of recruiting, broadening the audience to other professional networkers who have achieved huge success with functional beverages; our timing could not be better."
Avidus Management Group Inc. (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary, Asantae, Inc. (www.asantae.com) develops, produces and markets innovative nutritional products through direct and network marketing channels. The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stress, and support a healthy immune system that, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.).
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Certain information in this news release is forward-looking within the meaning of certain securities laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among other things, information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions, including the listing and trading of the Company's common shares on the Exchange. The words "may", "could", "should", "would", "suspect", "outlook", "believe", "anticipate", "estimate", "expect", "intend", "plan", "target" and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of the date of this news release.
The results or events anticipated or predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from such forward- looking information include, among others, the Company's ability to develop new products which will receive market acceptance, to receive market acceptance in new markets outside the United States, to engage and retain qualified key personnel, employees and affiliates, to obtain capital and credit and to protect its intellectual property rights.
The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not cause such forward-looking information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME.
SOURCE: Avidus Management Group Inc.
For further information:
For further information respecting the Company please contact:
Daniel Lundell, CEO/COO
10153 E. Hampton Ave., Suite 101
Mesa, AZ 85209
P: 480-278-8702 / F: 480-907-2641
Sequoia Partners Inc.